Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andreas Puzik

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Archiv Der Pharmazie|August 10, 2016
Canthin-4-ones as Novel Antibacterial AgentsTim Tremmel, Andreas Puzik, André P Gehring, et al.
Pharmaceutics|September 28, 2021
Formulation Development of Sublingual Cyclobenzaprine Tablets Empowered by Standardized and Physiologically Relevant Ex Vivo Permeation StudiesHaidara Majid, Andreas Puzik, Tanja Maier, et al.
International Journal of Pharmaceutics|April 8, 2021
Exploring the transmucosal permeability of cyclobenzaprine: A comparative preformulation by standardized and controlled ex vivo and in vitro permeation studiesHaidara Majid, Andreas Puzik, Tanja Maier, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Archiv Der Pharmazie|August 10, 2016
Canthin-4-ones as Novel Antibacterial AgentsTim Tremmel, Andreas Puzik, André P Gehring, et al.
Pharmaceutics|September 28, 2021
Formulation Development of Sublingual Cyclobenzaprine Tablets Empowered by Standardized and Physiologically Relevant Ex Vivo Permeation StudiesHaidara Majid, Andreas Puzik, Tanja Maier, et al.
International Journal of Pharmaceutics|April 8, 2021
Exploring the transmucosal permeability of cyclobenzaprine: A comparative preformulation by standardized and controlled ex vivo and in vitro permeation studiesHaidara Majid, Andreas Puzik, Tanja Maier, et al.
Pageof 1